| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,815 |
13,089 |
$2.08M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,570 |
6,123 |
$1.54M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,166 |
9,724 |
$925K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,871 |
5,222 |
$730K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,726 |
1,651 |
$560K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
7,775 |
7,357 |
$489K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,928 |
1,889 |
$395K |
| A0425 |
Ground mileage, per statute mile |
3,562 |
2,832 |
$392K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,543 |
4,011 |
$323K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
1,149 |
965 |
$255K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,269 |
1,642 |
$237K |
| 71046 |
Radiologic examination, chest; 2 views |
4,313 |
4,199 |
$205K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,595 |
1,495 |
$201K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,483 |
4,805 |
$196K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,193 |
3,731 |
$165K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,518 |
1,499 |
$153K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
718 |
652 |
$151K |
| 71045 |
Radiologic examination, chest; single view |
2,986 |
2,843 |
$149K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,320 |
2,266 |
$143K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,460 |
1,420 |
$138K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
4,716 |
2,233 |
$134K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,683 |
3,428 |
$109K |
| 97162 |
|
1,453 |
1,446 |
$85K |
| 80053 |
Comprehensive metabolic panel |
20,625 |
18,815 |
$77K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,080 |
8,770 |
$76K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,028 |
1,963 |
$68K |
| 80061 |
Lipid panel |
6,943 |
6,791 |
$66K |
| 36415 |
Collection of venous blood by venipuncture |
28,874 |
25,073 |
$66K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,048 |
1,040 |
$60K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
562 |
550 |
$59K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
382 |
375 |
$59K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,737 |
21,637 |
$57K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
916 |
907 |
$51K |
| 73564 |
|
1,236 |
1,228 |
$40K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,069 |
2,020 |
$38K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,068 |
2,019 |
$38K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,202 |
2,133 |
$38K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,208 |
6,063 |
$37K |
| 73630 |
|
1,682 |
1,637 |
$35K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
485 |
477 |
$35K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,583 |
5,246 |
$34K |
| 72110 |
|
783 |
775 |
$29K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
557 |
166 |
$29K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
1,126 |
1,110 |
$29K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,343 |
1,320 |
$25K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,272 |
1,104 |
$24K |
| 76830 |
Ultrasound, transvaginal |
311 |
309 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,721 |
2,658 |
$21K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,477 |
617 |
$19K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
115 |
113 |
$18K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
540 |
528 |
$18K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,217 |
1,186 |
$15K |
| 73130 |
|
1,102 |
1,078 |
$15K |
| 73030 |
|
702 |
687 |
$14K |
| 84439 |
|
2,611 |
2,488 |
$14K |
| 73610 |
|
886 |
871 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,278 |
5,785 |
$13K |
| 82728 |
|
1,387 |
1,328 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,704 |
3,513 |
$11K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
607 |
589 |
$10K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
272 |
270 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
238 |
238 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,334 |
2,989 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,388 |
2,335 |
$8K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
436 |
427 |
$8K |
| 97161 |
|
190 |
188 |
$8K |
| 82607 |
|
939 |
912 |
$8K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
34 |
24 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
965 |
946 |
$7K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
57 |
54 |
$7K |
| 73110 |
|
373 |
360 |
$6K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
55 |
55 |
$6K |
| 83735 |
|
6,469 |
5,546 |
$6K |
| 82570 |
|
1,915 |
1,805 |
$6K |
| 82043 |
|
1,491 |
1,455 |
$5K |
| 83880 |
|
1,438 |
1,351 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
350 |
350 |
$5K |
| 87186 |
|
1,871 |
1,819 |
$5K |
| 85027 |
|
1,463 |
1,400 |
$5K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
13 |
13 |
$5K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
42 |
38 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
132 |
91 |
$5K |
| 86140 |
|
5,788 |
5,347 |
$5K |
| 86900 |
|
79 |
77 |
$4K |
| 87077 |
|
1,976 |
1,736 |
$4K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
342 |
331 |
$4K |
| 85610 |
|
2,627 |
2,133 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,772 |
868 |
$4K |
| 81025 |
|
3,622 |
3,474 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
13 |
$4K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
32 |
26 |
$3K |
| 81001 |
|
9,541 |
8,906 |
$3K |
| 85652 |
|
2,259 |
2,125 |
$3K |
| 74022 |
|
478 |
469 |
$3K |
| 84702 |
|
383 |
281 |
$3K |
| 83540 |
|
669 |
638 |
$3K |
| 87634 |
|
161 |
161 |
$2K |
| 86780 |
|
263 |
214 |
$2K |
| 97163 |
|
39 |
39 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
218 |
193 |
$2K |
| 83550 |
|
412 |
395 |
$2K |
| 83690 |
|
4,037 |
3,736 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
28 |
13 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
63 |
63 |
$2K |
| 82746 |
|
182 |
177 |
$2K |
| 72050 |
|
26 |
26 |
$2K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
26 |
26 |
$1K |
| 81003 |
|
1,029 |
994 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
140 |
70 |
$1K |
| 72070 |
|
18 |
18 |
$1K |
| 87081 |
|
1,506 |
1,470 |
$1K |
| 87340 |
|
231 |
226 |
$1K |
| 82248 |
|
532 |
459 |
$964.79 |
| 87088 |
|
350 |
343 |
$946.17 |
| 76642 |
|
25 |
25 |
$935.55 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,462 |
1,141 |
$926.12 |
| 82150 |
|
2,389 |
2,272 |
$921.64 |
| 71271 |
|
12 |
12 |
$850.41 |
| 80076 |
|
449 |
417 |
$828.40 |
| 84703 |
|
1,149 |
1,115 |
$709.89 |
| 87070 |
|
304 |
295 |
$639.17 |
| 86850 |
|
65 |
65 |
$625.67 |
| 93225 |
|
12 |
12 |
$612.85 |
| 73502 |
|
41 |
40 |
$579.35 |
| 85730 |
|
841 |
808 |
$513.59 |
| 85379 |
|
1,320 |
1,284 |
$469.25 |
| 77065 |
Tomosynthesis, mammo |
12 |
12 |
$438.50 |
| 86038 |
|
69 |
67 |
$411.01 |
| 74018 |
|
27 |
25 |
$376.64 |
| 80305 |
|
691 |
668 |
$341.15 |
| 86803 |
|
41 |
41 |
$337.81 |
| 87807 |
|
326 |
317 |
$308.08 |
| 87205 |
|
290 |
283 |
$303.91 |
| 97802 |
|
13 |
13 |
$260.00 |
| 84484 |
|
4,077 |
3,238 |
$235.40 |
| 87040 |
|
1,994 |
1,159 |
$229.32 |
| 83605 |
|
5,942 |
5,353 |
$214.35 |
| 87210 |
|
62 |
62 |
$159.09 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
12 |
12 |
$153.24 |
| 86039 |
|
27 |
26 |
$152.63 |
| 84481 |
|
13 |
12 |
$140.47 |
| 82077 |
|
998 |
915 |
$135.74 |
| 82962 |
|
1,343 |
1,100 |
$113.53 |
| 80306 |
|
696 |
658 |
$102.11 |
| 82565 |
|
36 |
26 |
$97.16 |
| 83655 |
|
14 |
13 |
$89.35 |
| 84100 |
|
41 |
37 |
$73.04 |
| 85018 |
|
57 |
55 |
$55.33 |
| 85014 |
|
54 |
52 |
$50.86 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,135 |
940 |
$47.75 |
| 86431 |
|
14 |
14 |
$38.52 |
| 84550 |
|
13 |
12 |
$33.90 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
431 |
393 |
$28.70 |
| 84156 |
|
14 |
12 |
$27.77 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
150 |
149 |
$18.00 |
| 83874 |
|
360 |
318 |
$16.24 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,277 |
2,229 |
$12.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,713 |
3,337 |
$3.15 |
| J2704 |
Injection, propofol, 10 mg |
1,734 |
1,679 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
625 |
543 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
739 |
498 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,092 |
1,019 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
949 |
889 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,253 |
3,995 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
118 |
108 |
$0.00 |
| 86901 |
|
79 |
77 |
$0.00 |
| 96376 |
|
175 |
142 |
$0.00 |
| 36000 |
|
12 |
12 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
26 |
25 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
40 |
37 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
20 |
20 |
$0.00 |
| 72040 |
|
12 |
12 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
60 |
52 |
$0.00 |
| 12001 |
|
13 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,625 |
1,571 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
649 |
602 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
207 |
188 |
$0.00 |
| 90715 |
|
137 |
135 |
$0.00 |
| 80143 |
|
145 |
141 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
130 |
95 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
37 |
32 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
102 |
97 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
88 |
78 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
53 |
38 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
48 |
46 |
$0.00 |
| 80179 |
|
155 |
151 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
16 |
12 |
$0.00 |
| 93226 |
|
12 |
12 |
$0.00 |